LASSO regression to identify predictors and model construction for postoperative residual pain in patients with osteoporotic vertebral compression fracture
-
摘要:
目的 探讨骨质疏松性椎体压缩骨折(OVCF)患者经皮穿刺椎体成形术(PVP)术后残余疼痛的因素,并基于LASSO模型筛选相关因素构建Nomgram模型,旨在为早期识别术后残余疼痛高危人群提供参考。 方法 采用回顾性研究,将2022年1月—2023年12月杭州市富阳中医骨伤医院PVP术后存在残余疼痛的60例OVCF患者纳入残余疼痛组,将同期无残余疼痛的60例患者纳入无残余疼痛组。比较2组基线资料、围手术期指标;采用LASSO回归筛选相关危险因素进行logistic回归分析,构建Nomgram模型并进行内部验证。 结果 通过LASSO回归模型筛选出6个潜在的相关因素,经logistic回归分析,结果显示,TLF损伤、骨水泥渗漏、关节突关节侵扰、骨水泥注入量多是影响OVCF患者PVP术后残余疼痛的独立危险因素(OR>1,P<0.05),骨密度(BMD)T值高、术后椎体高度恢复率高是保护因素(OR<1,P<0.05);Nomgram模型结果显示,C-index值为0.926,模型具有良好的区分度,校准曲线整体趋势接近理想曲线,ROC曲线显示,列线图预测OVCF患者PVP术后残余疼痛的AUC为0.926,预测价值较高。 结论 基于BMD T值、TLF损伤、骨水泥渗漏、关节突关节侵扰、骨水泥注入量、术后椎体高度恢复率构建OVCF患者PVP术后残余疼痛Nomgram模型,可有效预测OVCF患者PVP术后残余疼痛的风险。 -
关键词:
- 骨质疏松性椎体压缩骨折 /
- 残余疼痛 /
- LASSO模型 /
- 影响因素 /
- Nomgram模型
Abstract:Objective To investigate factors of residual pain following percutaneous vertebroplasty (PVP) in patients with osteoporotic vertebral compression fracture (OVCF) and to construct a Nomgram model based on LASSO regression for identifying relevant factors. This aims to provide reference for early identification of high-risk groups for postoperative residual pain. Methods A retrospective study was conducted on the efficacy of acceptance commitment therapy combined with a collaborative care model in esophageal cancer patients undergoing radiotherapy and chemotherapy. Clinical data of 60 OVCF patients with residual pain after PVP surgery from January 2022 to December 2023 in Fuyang Traditional Chinese Medicine Orthopedics and Trauma Hospital were included in the residual pain group, while clinical data of 60 patients without residual pain during the same period were included in the no residual pain group. Compare the baseline data and perioperative indicators of the two groups. Utilize LASSO regression to identify relevant risk factors and perform logistic regression analysis to develop a nomogram model with internal validation. Results Six potential related factors were screened using the LASSO regression model. The results of logistic regression analysis showed that TLF injury, bone cement leakage, facet joint invasion, and excessive bone cement injection were independent risk factors affecting residual pain in OVCF patients after PVP surgery (OR>1, P < 0.05). In contrast, high BMD T values and significant postoperative vertebral height recovery rate were identified as protective factors (OR < 1, P < 0.05). The constructed Nomgram model exhibited a C-index value of 0.926, indicating strong discrimination. The overall trend of the calibration curve was close to the ideal curve. The ROC curve analysis predicted an AUC of 0.926 for residual pain after PVP in OVCF patients, indicating high predictive validity. Conclusion A Nomogram model incorporating BMD T value, TLF injury, bone cement leakage, facet joint invasion, bone cement injection volume, and postoperative vertebral height recovery rate, can effectively predict the risk of residual pain in OVCF patients after PVP surgery. -
表 1 2组骨质疏松性椎体压缩骨折患者基线资料比较
Table 1. Comparison of baseline data between the two groups of patients with osteoporotic vertebral compression fractures
项目 残余疼痛组(n=60) 无残余疼痛组(n=60) 统计量 P值 年龄(x±s,岁) 70.52±5.12 69.94±5.09 0.622a 0.535 BMI(x±s) 21.94±1.09 22.12±1.13 0.888a 0.376 性别[例(%)] 0.240b 0.624 男性 9(15.00) 11(18.33) 女性 51(85.00) 49(81.67) 糖尿病[例(%)] 0.100b 0.752 有 5(8.33) 6(10.00) 无 55(91.67) 54(90.00) 高血压[例(%)] 0.436b 0.509 有 6(10.00) 4(6.67) 无 54(90.00) 56(93.33) 骨折椎体部位[例(%)] 0.539b 0.463 胸椎 29(48.33) 25(41.67) 腰椎 31(51.67) 35(58.33) 腰背疼痛史[例(%)] 0.320b 0.572 有 21(35.00) 24(40.00) 无 39(65.00) 36(60.00) TLF损伤[例(%)] 10.848b 0.001 是 41(68.33) 23(38.33) 否 19(31.67) 37(61.67) 邻椎骨折[例(%)] 0.137b 0.711 是 26(43.33) 24(40.00) 否 34(56.67) 36(60.00) ASA分级[例(%)] 0.154b 0.695 Ⅰ~Ⅱ级 40(66.67) 42(70.00) Ⅲ级 20(33.33) 18(30.00) BMD T值(x±s,SD) -3.95±0.53 -3.45±0.51 -5.264a <0.001 骨水泥渗漏[例(%)] 14.704b <0.001 是 40(66.67) 19(31.67) 否 20(33.33) 41(68.33) 关节突关节侵扰[例(%)] 17.638b <0.001 是 41(68.33) 18(30.00) 否 19(31.67) 42(70.00) 术前椎体高度压缩率(x±s,%) 37.62±6.52 36.94±6.47 0.573a 0.567 手术时间(x±s,min) 49.82±5.12 48.62±4.96 1.304a 0.195 骨水泥注入量(x±s,mL) 5.94±1.23 5.17±1.15 3.587a <0.001 术后椎体高度恢复率(x±s,%) 38.82±4.16 43.27±4.45 5.653a <0.001 术后Cobb角改善率(x±s,%) 59.58±6.01 61.16±6.12 1.427a 0.156 注:a为t值,b为χ2值。 表 2 变量赋值情况
Table 2. Variable assignment
变量 赋值方法 BMD T值 连续变量,以实际值赋值 TLF损伤 是=1,否=0 骨水泥渗漏 是=1,否=0 关节突关节侵扰 是=1,否=0 骨水泥注入量 连续变量,以实际值赋值 术后椎体高度恢复率 连续变量,以实际值赋值 表 3 OVCF患者PVP术后残余疼痛影响因素的回归分析
Table 3. Regression analysis of factors influencing residual pain post-PVP in patients with OVCF
变量 B SE Waldχ2 P值 OR值 95% CI BMD T值 -1.794 0.577 9.652 0.002 0.166 0.054~0.516 TLF损伤 1.278 0.611 4.376 0.036 3.591 1.084~11.895 骨水泥渗漏 1.265 0.576 4.819 0.028 3.544 1.145~10.966 关节突关节侵扰 1.319 0.594 4.929 0.026 3.740 1.167~11.987 骨水泥注入量 0.872 0.294 8.786 0.003 2.393 1.344~4.260 术后椎体高度恢复率 -0.328 0.087 14.194 <0.001 0.721 0.608~0.855 -
[1] ALSOOF D, ANDERSON G, MCDONALD C L, et al. Diagnosis and management of vertebral compression fracture[J]. Am J Med, 2022, 135(7): 815-821. doi: 10.1016/j.amjmed.2022.02.035 [2] 安忠诚, 陈晨, 董黎强, 等. 经皮椎体后凸成形术后邻近节段再骨折的危险因素分析[J]. 中华全科医学, 2022, 20(4): 591-593, 712. doi: 10.16766/j.cnki.issn.1674-4152.002407AN Z C, CHEN C, DONG L Q, et al. Risk factors for adjacent segment refracture after percutaneous kyphoplasty[J]. Chinese Journal of General Practice, 2022, 20(4): 591-593, 712. doi: 10.16766/j.cnki.issn.1674-4152.002407 [3] HAIBIER A, YUSUFU A, LIN H, et al. Effect of different cement distribution in bilateral and unilateral percutaneous vertebro plasty on the clinical efficacy of vertebral compression fractures[J]. BMC Musculoskelet Disord, 2023, 24(1): 908. DOI: 10.1186/s12891-023-06997-4. [4] 中国康复医学会骨质疏松预防与康复专业委员会. 骨质疏松性椎体压缩骨折诊治专家共识(2021版)[J]. 中华医学杂志, 2021, 101(41): 3371-3379. doi: 10.3760/cma.j.cn112137-20210625-01436Chinese Rehabilitation Medicine Association Osteoporosis Prevention and Rehabilitation Professional Committee. Expert consensus on the diagnosis and treatment of osteoporotic vertebral compression fractures (2021 Edition)[J]. National Medical Journal of China, 2021, 101(41): 3371-3379. doi: 10.3760/cma.j.cn112137-20210625-01436 [5] 中华医学会放射学分会介入学组. 经皮椎体成形术操作技术专家共识[J]. 中华放射学杂志, 2014, 48(1): 6-9.Interventional Group of Radiology Branch of Chinese Medical Association. Expert consensus on percutaneous vertebroplasty operation technology[J]. Chinese Journal of Radiology, 2014, 48(1): 6-9. [6] PEDROSA E, SILVA M, LOBO A, et al. Is the asa classification universal?[J]. Turk J Anaesthesiol Reanim, 2021, 49(4): 298-303. doi: 10.5152/TJAR.2021.103 [7] LIN M M, WEN X M, HUANG Z W, et al. A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures[J]. Osteoporos Int, 2023, 34(4): 749-762. doi: 10.1007/s00198-023-06681-2 [8] WANG R J, XU Y Y, MA X L. Risk factors and strategies for recovery quality, postoperative pain, and recurrent fractures between percutaneous kyphoplasty and percutaneous vertebroplasty in elderly patients with thoracolumbar compression fractures: a retrospective comparative cohort study[J]. Ann Transl Med, 2023, 11(2): 122. DOI: 10.21037/atm-22-6475. [9] 陈晨, 安忠诚, 吴连国, 等. 椎体强化术后早期与后期残留腰背痛的原因分析[J]. 中国骨伤, 2022, 35(8): 724-731.CHEN C, AN Z C, WU L G, et al. Analysis of the causes of residual back pain in the early and late stages after percutaneous vertebral augmentation[J]. China Journal of Orthopaedics and Traumatology, 2022, 35(8): 724-731. [10] 付海军, 冯毅, 武太勇, 等. 经皮椎体成形术椎间盘骨水泥渗漏对相邻椎体生物力学影响的有限元分析[J]. 北京生物医学工程, 2022, 41(2): 140-147.FU H J, FENG Y, WU T Y, et al. Finite element analysis of biomechanical effect of intervertebral disc cement leakage on adjacent vertebrae after percutaneous vertebroplasty[J]. Beijing Biomedical Engineering, 2022, 41(2): 140-147. [11] 郭存良, 崔凯莹, 郝延科. 不同骨水泥注入量对经皮椎体后凸成形术治疗骨质疏松性椎体压缩骨折疗效的影响[J]. 临床骨科杂志, 2022, 25(2): 153-156.GUO C L, CUI K Y, HAO Y K, et al. Effect of different volume of bone cement injection on the efficacy of percutaneous kyphoplas-ty in the treatment of osteoporotic vertebral compression fractures[J]. Journal of Clinical Orthopedics, 2022, 25(2): 153-156. [12] LI Y, YUE J X, HUANG M Y, et al. Risk factors for postoperative residual back pain after percutaneous kyphoplasty for osteoporotic vertebral compression fractures[J]. Eur Spine J, 2020, 29(10): 2568-2575. doi: 10.1007/s00586-020-06493-6 [13] PAYO-OLLERO J, LLOMBART-BLANCO R, VILLAS C, et al. Vertebral body height changes in acute symptomatic osteoporotic vertebral compression fractures treated with vertebral cement augmentation-which factors affect vertebral body height during follow-up? A multiple linear regression study[J]. Geriatrics (Basel), 2022, 7(6): 142. DOI: 10.3390/geriatrics7060142. [14] ARGYROU C, KARLAFTI E, LAMPROPOULOU-ADAMIDOU K, et al. Effect of calcium and vitamin d supplementation with and without collagen peptides on bone turnover in postmenopausal women with osteopenia[J]. J Musculoskelet Neuronal Interact, 2020, 20(1): 12-17. [15] 吴海波, 禹志军, 白曼莫. 骨质疏松性椎体压缩骨折椎体成形修复效果与骨水泥注入量及弥散程度的关系[J]. 中国组织工程研究, 2020, 24(16): 2473-2477.WU H B, YU Z J, BAI M M. Correlation of percutaneous vertebroplasty effect on osteoporotic vertebral compression fracture with injection amount and dispersion degree of bone cement[J]. Chinese Journal of Tissue Engineering, 2020, 24(16): 2473-2247. [16] 徐军平, 王莉, 朱昊强, 等. 正位透视法在经皮椎体成形术治疗骨质疏松性椎体压缩骨折中的应用[J]. 临床骨科杂志, 2023, 26(4): 475-479.XU J P, WANG L, ZHU H Q, et al. Application of anteroposterior fluoroscopy in the treatment of osteoporotic vertebral compres-sion fracture treated by percutaneous vertebroplasty[J]. Journal of Clinical Orthopedics, 2023, 26(4): 475-479.